Jena D French

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers
    Jena D French
    Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado, Aurora, CO 80045, USA
    Thyroid 23:529-42. 2013
  2. pmc Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer
    Jena D French
    University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 97:E934-43. 2012
  3. pmc Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer
    Jena D French
    Department of Medicine, University of Colorado Denver, 12801 East 17th Avenue, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 95:2325-33. 2010
  4. doi request reprint PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer
    Jill J Severson
    Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado
    Cancer Immunol Res 3:620-30. 2015
  5. pmc Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer
    Rebecca E Schweppe
    Division of Endocrinology, Diabetes, and Metabolism, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 94:2199-203. 2009

Collaborators

Detail Information

Publications5

  1. doi request reprint Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers
    Jena D French
    Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado, Aurora, CO 80045, USA
    Thyroid 23:529-42. 2013
    ..Concurrent inflammation has long been associated with follicular cell-derived thyroid cancer (FDTC). In the last decade, much research has focused on characterizing the tumor-associated immune response in patients with FDTC...
  2. pmc Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer
    Jena D French
    University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 97:E934-43. 2012
    ..Novel prognostic markers may be helpful in guiding a therapeutic approach. Our previous studies revealed that immune suppression is evident in PTC and associated with more severe disease...
  3. pmc Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer
    Jena D French
    Department of Medicine, University of Colorado Denver, 12801 East 17th Avenue, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 95:2325-33. 2010
    ..Immune-based therapies are under investigation to treat many types of cancer. The role of the immune system in PTC is poorly understood...
  4. doi request reprint PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer
    Jill J Severson
    Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado
    Cancer Immunol Res 3:620-30. 2015
    ..Therapies that release the effects of PD-1 and Tim-3 and reduce the suppressive effects of Tregs may encourage tumor elimination in patients with mDTC...
  5. pmc Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer
    Rebecca E Schweppe
    Division of Endocrinology, Diabetes, and Metabolism, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 94:2199-203. 2009
    ..The role of the Src-FAK complex has not been characterized in papillary and anaplastic thyroid cancer (PTC and ATC)...